Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials | White Papers
Search Refinements

Clinical Trials White Papers

View white papers from other Pharmaceutical sectors:
76-90 of 139 results
Operational Excellence (OPEX) through Optimization
| By COPA-DATA
As an automation supplier to many different industries, COPA-DATA sees how important mapping the process - and any connecting processes - in the visualization, and then presenting the information to the operator in the format most suited to them, can be in terms of efficiency gains. The operator influences the quality and efficiency of production.
Contract Research & Services > Clinical Trials > White Papers
zenon in Pharma: Enhancing Pharmaceutical Production
| By COPA-DATA
COPA-DATA enhances pharmaceutical production with its sophisticated visualization software. And, through market penetration, zenon is gaining recognition for advanced pharmaceutical solutions. The rigors of regulation and validation, which impact on patient safety and business risk for the regulated producer, have been accommodated in zenon. Over the years, our customers’ experiences have informed the further streamlining and advancement of the product.
Contract Research & Services > Clinical Trials > White Papers
reMYND’s APP-London model and its bigenic combination with PS1[A246E]
| By reMYND
reMYND's APP[V717I] and APP[V717I] x PS1[A246E] transgenic amyloidopathy mouse models – biochemical and immunohistochemical characterization.
Contract Research & Services > Clinical Trials > White Papers
reMYND’s TAU[P301L] model and its bigenic combination with APP-London
| By reMYND
reMYND’s TAU[P301L] transgenic tauopathy mouse model – biochemical and immunohistochemical characterization.
Contract Research & Services > Clinical Trials > White Papers
Concise overview presentation of reMYND’s Contract Research Offering
| By reMYND
As experts in compound testing in highly validated, proprietary Alzheimer transgenic mice, we can offer you an extensive scope of in-vivo testing and ample support in study design and data interpretation.
Contract Research & Services > Clinical Trials > White Papers
One-page brochure of reMYND’s CRO
| By reMYND
Helping you understand the therapeutic in vivo effects of your Alzheimer drug candidates.
Contract Research & Services > Clinical Trials > White Papers
Review paper discussing the pathological hallmarks, clinical parallels, and value for drug testing in Alzheimer’s disease of the APP[V717I] London transgenic mouse model; also touching on reMYND’s other proprietary transgenic mouse models (Tanghe et al., 2010).
| By reMYND
Notwithstanding the vast amount of resources invested into discovery and development of new targets and treatments, Alzheimer’s disease (AD) remains an indication with enormous unmet needs. One complicating factor for successful drug development is the unknown etiology of idiopathic AD. AD entails noxious aggregation of β-amyloid (Abeta) and Tau, representing fundamental processes in disease onset and progression
Contract Research & Services > Clinical Trials > White Papers
WHO Drug Dictionary Enhanced (WHO DDE) - Clinical
| By The Uppsala Monitoring Centre
The Uppsala Monitoring Centre (UMC) WHO Drug Dictionary Enhanced (WHO DDE) is the most comprehensive and actively used drug coding reference work in the world. The information it contains helps ensure that clinical trial data is accurately coded, analysed, interpreted and reported. Most critically, WHO DDE meets the expressed need for a consistent drug dictionary and exact terminology when coding concomitant medications to accelerate submissions to national regulatory authorities.
Contract Research & Services > Clinical Trials > White Papers
The WHO Drug Dictionary User Group
| By The Uppsala Monitoring Centre
As a subscriber to any of our products and services within the WHO Drug Dictionaries, you have access to the Uppsala Monitoring Centre (UMC) User Group Portal. Here you will find User Guides, Best Practices, minutes and materials from User Group Meetings as well as information about the latest updates to the WHO Drug Dictionaries. Our Support team will always assist you with information about how we you can get the most from UMC products and services in your daily work.
Contract Research & Services > Clinical Trials > White Papers
Standardised Drug Groupings (SDG)
| By The Uppsala Monitoring Centre
Subscribers to the Uppsala Monitoring Centre (UMC) WHO Drug Dictionary Enhanced (WHO DDE) have many uses for the dictionary’s unique coding system for medicinal products, their active substances and their therapeutic effects.
Contract Research & Services > Clinical Trials > White Papers
WHO Drug Dictionary Enhanced (WHO DDE)
| By The Uppsala Monitoring Centre
The Uppsala Monitoring Centre (UMC) WHO Drug Dictionary Enhanced (WHO DDE) is the most comprehensive and actively used drug coding reference work in the world. The information it contains helps ensure that clinical trial data is accurately coded, analysed, interpreted and reported. Most critically, WHO DDE meets the expressed need for a consistent drug dictionary and exact terminology when coding concomitant medications to accelerate submissions to national regulatory authorities.
Contract Research & Services > Clinical Trials > White Papers
WHO Drug Dictionaries
| By The Uppsala Monitoring Centre
Uppsala Monitoring Centre (UMC) WHO Drug Dictionaries and related services optimize the global coding, analysis and reporting of medical product information from clinical trials and within drug safety. Since all use the same working methods and terminologies, users can easily apply the drug coding principles across the whole series.
Contract Research & Services > Clinical Trials > White Papers
Drug Safety Solutions
| By Pierrel Research
The safety of medicines is an essential part of patient safety. The rapidly increasing scrutiny on drug safety issues, and an increasing number of regulations and risk management commitments have led to increased safety data collection, analysis and regulatory surveillance, which in turn have increased costs.
Contract Research & Services > Clinical Trials > White Papers
International Clinical Supply Solutions
| By Pierrel Research
Our high quality Investigational Medicinal Product (IMP) services include contract IMP manufacture (packaging, labeling, certification by QP in accordance with Directive 2001/20/EC) and IMP logistics tailored to meet the specific requirements of phase I through phase IV clinical trials.
Contract Research & Services > Clinical Trials > White Papers
Keeping the cold chain on the level
| By TSS
Maintaining an optimal temperature is vital during the transit of pharmaceutical products. The data captured as evidence of product conditions must be of the highest possible quality or the entire cold chain is put at risk. Temperature monitoring services provider TSS’s cold chain information system offers shipment analysis from a risk management perspective.
Contract Research & Services > Clinical Trials > White Papers
76-90 of 139 results